On the morning of October 10th, the signing ceremony for the establishment of the Lubei Medical Laboratory Center by Binzhou Xinyue Rehabilitation Hospital and Linaxin Biotechnology was held at Linaxin Biotechnology's Kunshan headquarters. Cai Jianfeng, Secretary of the Party Committee of Shandong Xinyue Health Technology Co., Ltd., Wang Chunkai, General Manager, and Yang Wendi, Deputy General Manager of the Sales Company; Guo Wenjiang, member of the Standing Committee of the People's Congress of Binzhou City and Chairman of the Overseas Chinese Affairs Committee, and Guang Dengzhi, General Manager of Binzhou High tech Zone Medical and Health Industry Park Co., Ltd; Tan Shengwei, General Manager of Linaxin Biotechnology, Professor Liu Quanjun, Chief Technology Officer, Zhu Wanjie, Vice President, Yin Zhongcheng, Dean of Health Management, and Li Hui, General Manager of the Medical Laboratory Center stationed in Shandong, attended the signing ceremony.

Binzhou Xinyue Rehabilitation Hospital is the main carrier of the medical and health care sector under Shandong Xinyue Health Technology Co., Ltd. It is a comprehensive health care demonstration base with medical centers, health care centers, nutrition centers, and training centers as its core. It is a modern hospital that focuses on prevention testing and rehabilitation, integrating medical treatment, teaching, scientific research, and preventive health care. The hospital is based on meeting the needs of different groups of people, establishing a management service system and sharing platform for the community and high-end population. On the one hand, it provides on-site home services through community assistance and remote customization, and on the other hand, it provides high-precision and comprehensive health management services for people with higher health management needs.

Linaxin Biotechnology is a technology-based enterprise specializing in home cancer early screening. It was jointly founded by leading talents, domestic and foreign biomedical PhDs, and gene sequencing scientists. The expert committee is composed of national Changjiang Scholars, professors, clinical experts from tumor hospitals, etc. It has a 1500 square meter GMP production base of 100000 and 10000 levels, 5 international advanced level cancer early screening in vitro diagnostic kit production lines, more than 20 independent intellectual property patents, and a product FOB (Chang Lexin) for fecal occult blood ™）， Transferrin TF (Changweile) ™） Early assessment of gastric cancer, Helicobacter pylori (Youlekang) ™)， Fecal FOB Multi Target DNA Mutation Detection Reagent (Li Changsheng) ™）， Simultaneously deploying early screening for digestive tract tumors such as gastric cancer, liver cancer, and esophageal cancer, and applying portable fourth generation nanopore chip technology for cancer early screening. In 2019, it won the leading technology special project of "Kunshan Double Creation", the third prize of Suzhou Maker Paradise Industry Competition, the "Excellence Award" of Kunshan Innovation Bridge+Employment Dream, and in 2020, it was awarded as an excellent entrepreneurial project in Kunshan and Jiangsu Province.

Both parties cooperate to jointly establish an inspection center, fully leveraging their respective resource advantages in their fields, achieving complementary advantages, common development, and shared achievements. After the establishment of the inspection center, it expanded to northern Shandong, radiated to Shandong, and served the whole country. Both parties will establish a testing center to jointly build a complete medical testing platform and a big health management platform, and carry out in-depth cooperation in early detection, early detection, and early prevention of cancer, creating a new intelligent home testing system for early cancer that integrates research and development, production, sales, and testing. Customers can place orders and purchase services independently online or offline on the platform, or view test results at home and receive one-on-one professional guidance from medical staff online, with real-time monitoring of the entire service process. At the same time, the platform also provides a full range of services including intervention, diet, lifestyle, and rehabilitation, continuously improving chronic disease management such as disease prevention and control, and providing residents with more comprehensive health management plans.

Screen a sample early, save a life, benefit a family, and improve people's health level!